Newsfeeds - Spark Newswire

1 minute read

Earnings

Earnings Preview: Alkermes

July 26, 10:29 AM

Alkermes (NASDAQ:ALKS) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Alkermes will report an earnings per share (EPS) of $0.01.

ALKS

3 minute read

Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?

By Zacks

July 12, 1:33 PM

Image sourced from Shutterstock

3 minute read

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More

By Shanthi Rexaline

June 5, 4:09 PM

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

ACER

4 minute read

62 Biggest Movers From Yesterday

By Lisa Levin

April 28, 4:17 AM

Gainers Tenon Medical, Inc. (NASDAQ: TNON) rose 350% to clsoe at $22.50 on Wednesday after the company priced its IPO at $5.00 per share.

AFIB

4 minute read

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis

By Vandana Singh

April 27, 8:45 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ACHV

16 minute read

Earnings Scheduled For April 27, 2022

By Benzinga Insights

April 27, 5:04 AM

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.

ACGL

1 minute read

Earnings

Alkermes’s Earnings Outlook

By Benzinga Insights

April 26, 11:15 AM

Alkermes (NASDAQ:ALKS) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Alkermes will report an earnings per share (EPS) of $0.01.

ALKS

4 minute read

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

By Shanthi Rexaline

April 24, 5:34 PM

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering rate hike fears.

ABBV